<DOC>
	<DOC>NCT01307046</DOC>
	<brief_summary>This study is being conducted to evaluate the efficacy of MK-0954A in essential hypertension participants who are not adequately controlled with losartan.</brief_summary>
	<brief_title>MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Inclusion criteria: Participant has a diagnosis of essential hypertension. Participant is not treated with antihypertensive medication and meets protocolspecified blood pressure criteria. Participant is treated with single antihypertensive medication, and meets protocolspecified blood pressure criteria. Participant is being treated with up to dual oral antihypertensive medications, and will be able to discontinue the prior antihypertensive medication. Participant has no clinically meaningful findings to be disqualified from the study at the discretion of the investigator. Exclusion criteria: Regarding hypertension, participant is currently taking &gt; 2 antihypertensive medications. Participant has a history of significant multiple and/or severe allergies to ingredients of Nulotan or Preminent and thiazide drug or related drug (i.e., sulfonamidecontaining "chlortalidone" medicines) Participant is, at the time of signing informed consent, a user of recreational or illicit drugs or a recent history within the last year of drug or alcohol abuse or dependence. Participant is pregnant or breastfeeding or expecting to conceive or has a positive pregnancy test at the screening visit. Participant is currently participating or has participated in a study with an investigational compound (except losartan at any doses) or device within 30 days of signing informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Essential hypertension</keyword>
	<keyword>Uncontrolled hypertension</keyword>
	<keyword>Antihypertensive agents</keyword>
	<keyword>Blood pressure</keyword>
</DOC>